Last update :
24/11/2020
References   References 4474  
Type : Manufacturer

Research teams :
Authors :
Title : Avelumab, Bavencio® - Summary of Product Characteristics Updated 01-Nov-2019
Reference : Merck - Pfizer 2019

Level of Evidence : 
Manufacturer\'s stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionAvelumab Anticancer drug
Stability in solutions Glass Sodium chloride 0,9% 3.2 mg/mL 20-25°C Protect from light
24 Hour
Stability in solutions Glass Sodium chloride 0,45% 3.2 mg/mL 20-25°C Protect from light
24 Hour
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 3.2 mg/mL 20-25°C Protect from light
24 Hour
Stability in solutions Polyvinyl chloride Sodium chloride 0,45% 3.2 mg/mL 20-25°C Protect from light
24 Hour
Stability in solutions Polypropylene Sodium chloride 0,9% 3.2 mg/mL 20-25°C Protect from light
24 Hour
Stability in solutions Polypropylene Sodium chloride 0,45% 3.2 mg/mL 20-25°C Protect from light
24 Hour
Stability in solutions Polyethylene Sodium chloride 0,9% 3.2 mg/mL 20-25°C Protect from light
24 Hour
Stability in solutions Polyethylene Sodium chloride 0,45% 3.2 mg/mL 20-25°C Protect from light
24 Hour
Stability in solutions Ethylene vinyl acetate Sodium chloride 0,9% 3.2 mg/mL 20-25°C Protect from light
24 Hour
Stability in solutions Ethylene vinyl acetate Sodium chloride 0,45% 3.2 mg/mL 20-25°C Protect from light
24 Hour

  Mentions Légales